Publications by authors named "Alvina Chu"

Claim this Profile
P
Pharmacokinetics, Safety, Tolerability, and Exploratory Efficacy of Upadacitinib in Children with Severe Atopic Dermatitis.
Yuli Qian, Eliza M Raymundo, Shuai Hao, Kristina Unnebrink, Gweneth F Levy, Alvina D Chu

Clin Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent transmission of multiple carbapenemases in a long-term acute-care hospital.
Danielle A Rankin, Maroya Spalding Walters, Luz Caicedo, Paige Gable, Heather A Moulton-Meissner, Alvina K Chu

Infect Control Hosp Epidemiol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic and exposure-response modelling to inform upadacitinib dose selection in adolescent and adult patients with atopic dermatitis.
Mohamed Ismail, Eva Doelger, Doerthe Eckert, Alan D Irvine, Alvina D Chu

Br J Clin Pharmacol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies.
Emma Guttman-Yassky, Jacob P Thyssen, Jonathan I Silverberg, Kim A Papp, Amy S Paller, Alvina D Chu

J Allergy Clin Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis: Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical Trials.
Eric L Simpson, Kim A Papp, Andrew Blauvelt, Chia-Yu Chu, H Chih-Ho Hong, Alvina D Chu

JAMA Dermatol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results.
Jonathan I Silverberg, Marjolein de Bruin-Weller, Thomas Bieber, Weily Soong, Kenji Kabashima, Alvina D Chu

J Allergy Clin Immunol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysis.
Norito Katoh, Yukihiro Ohya, Hiroyuki Murota, Masanori Ikeda, Xiaofei Hu, Alvina D Chu

JAAD Int· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Upadacitinib in Patients With Active Ankylosing Spondylitis and an Inadequate Response to Nonsteroidal Antiinflammatory Drug Therapy: One-Year Results of a Double-Blind, Placebo-Controlled Study and Open-Label Extension.
Atul Deodhar, Désirée van der Heijde, Joachim Sieper, Filip Van den Bosch, Walter P Maksymowych, Alvina D Chu

Arthritis Rheumatol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial.
Andrew Blauvelt, Henrique D Teixeira, Eric L Simpson, Antonio Costanzo, Marjolein De Bruin-Weller, Alvina D Chu

JAMA Dermatol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials.
Emma Guttman-Yassky, Henrique D Teixeira, Eric L Simpson, Kim A Papp, Aileen L Pangan, Chia-Yu Chu, Alvina D Chu

Lancet· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Kristian Reich, Henrique D Teixeira, Marjolein de Bruin-Weller, Thomas Bieber, Weily Soong, Alvina D Chu

Lancet· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial.
Désirée van der Heijde, In-Ho Song, Aileen L Pangan, Atul Deodhar, Filip van den Bosch, Alvina D Chu

Lancet· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidrug-Resistant Campylobacter jejuni Outbreak Linked to Puppy Exposure - United States, 2016-2018.
Martha P Montgomery, Scott Robertson, Lia Koski, Ellen Salehi, Lauren M Stevenson, Alvina Chu

MMWR Morb Mortal Wkly Rep· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials.
Jeffrey Jones, Anthony Mato, Steven Coutre, John C Byrd, Richard R Furman, Alvina D Chu

Br J Haematol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Notes from the Field: Verona Integron-Encoded Metallo-Beta-Lactamase-Producing Pseudomonas aeruginosa Outbreak in a Long-Term Acute Care Hospital - Orange County, Florida, 2017.
Danielle Rankin, Luz Caicedo, Nychie Dotson, Paige Gable, Alvina Chu

MMWR Morb Mortal Wkly Rep· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Factors for Complete Response to Ibrutinib in Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of 2 Clinical Trials.
Susan M O'Brien, Samantha Jaglowski, John C Byrd, Rajat Bannerji, Kristie A Blum, Alvina D Chu

JAMA Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience.
Susan O'Brien, Richard R Furman, Steven Coutre, Ian W Flinn, Jan A Burger, Alvina D Chu

Blood· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study.
Susan O'Brien, Jeffrey A Jones, Steven E Coutre, Anthony R Mato, Peter Hillmen, Alvina D Chu

Lancet Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Th17-Associated Interstitial Kidney Inflammation in Lupus-Prone Mice Lacking the Gene Encoding STAT-1.
Gloria Yiu, Tue K Rasmussen, Bahareh Ajami, David J Haddon, Alvina D Chu

Arthritis Rheumatol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tracing Origins of the Salmonella Bareilly Strain Causing a Food-borne Outbreak in the United States.
Maria Hoffmann, Yan Luo, Steven R Monday, Narjol Gonzalez-Escalona, Andrea R Ottesen, Alvina Chu

J Infect Dis· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetramers reveal IL-17-secreting CD4+ T cells that are specific for U1-70 in lupus and mixed connective tissue disease.
Nicole H Kattah, Evan W Newell, Justin Ansel Jarrell, Alvina D Chu, Jianming Xie

Proc Natl Acad Sci U S A· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outbreak of Salmonella Newport infections linked to cucumbers--United States, 2014.
Kristina M Angelo, Alvina Chu, Madhu Anand, Thai-An Nguyen, Lyndsay Bottichio

MMWR Morb Mortal Wkly Rep· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
John C Byrd, Jennifer R Brown, Susan O'Brien, Jacqueline C Barrientos, Neil E Kay, Stephen J Schuster, Anna Schuh, Alvina D Chu

N Engl J Med· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fungal infections associated with contaminated methylprednisolone injections.
Rachel M Smith, Melissa K Schaefer, Marion A Kainer, Matthew Wise, Jennie Finks, Alvina Chu

N Engl J Med· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Campylobacter jejuni infections associated with unpasteurized milk--multiple States, 2012.
Allison H Longenberger, Aimee J Palumbo, Alvina K Chu, Mària E Moll, André Weltman

Clin Infect Dis· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis